Package Leaflet: Information for the User
Bisoprolol Tarbis Farma 2.5 mg film-coated tablets EFG
bisoprolol fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
The active substance in Bisoprolol Tarbis Farma is bisoprolol. Bisoprolol belongs to a group of medicines called beta-blockers. These medicines work by affecting the body's response to certain nerve impulses, especially in the heart. As a result, bisoprolol slows the heart rate and makes the heart more efficient at pumping blood throughout the body.
Heart failure occurs when the heart muscle is weak and unable to pump enough blood to meet the body's needs. Bisoprolol is used to treat stable chronic heart failure.
Bisoprolol is used in combination with other medicines suitable for this condition (such as ACE inhibitors, diuretics, and cardiac glycosides).
Do not take Bisoprolol Tarbis Farma
Do not take Bisoprolol Tarbis Farma if you have any of the following conditions:
Do not take Bisoprolol Tarbis Farma if you have any of the following heart problems:
Warnings and precautions
If you have any of the following problems, consult your doctor before taking Bisoprolol Tarbis Farma; your doctor may want to take special precautions (such as providing additional treatment or performing more frequent tests):
In addition, inform your doctor if you are going to undergo:
If you have chronic lung disease or less severe asthma, inform your doctor immediately if you start to notice breathing difficulties, cough, wheezing after exercise, etc. while using this medicine.
Children and adolescents
Bisoprolol is not recommended for use in children and adolescents.
Other medicines and Bisoprolol Tarbis Farma
Tell your doctor or pharmacist if you are taking or have recently taken or may take any other medicines.
Do not take the following medicines with bisoprolol without special advice from your doctor:
Consult your doctor before taking the following medicines with Bisoprolol Tarbis Farma; your doctor may need to monitor your condition more frequently:
Pregnancy and breastfeeding
Pregnancy
There is a risk that the use of bisoprolol during pregnancy may harm the baby. If you are pregnant or planning to become pregnant, inform your doctor. Your doctor will decide whether you can take this medicine during pregnancy.
Breastfeeding
It is not known whether bisoprolol passes into human breast milk. Therefore, breastfeeding is not recommended during treatment with bisoprolol.
Driving and using machines
Your ability to drive or use machines may be affected depending on how well you tolerate the medicine. Be especially careful at the start of treatment, when the dose is increased, or the medication is changed, and also in combination with alcohol.
Use in athletes
This medicine contains bisoprolol, which may produce a positive result in doping tests.
Follow exactly the instructions for administration of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
Treatment with bisoprolol requires regular monitoring by your doctor. This is especially important at the start of treatment, during dose increase, and when stopping treatment.
Take the tablet with a little water in the morning, with or without food. Do not crush or chew the tablet. The scored tablets can be divided into two equal doses.
Treatment with this medicine is usually long-term.
Adults, including the elderly
Treatment with bisoprolol should be started at a low dose and gradually increased.
Your doctor will decide how to increase the dose, and this will usually be done as follows:
The maximum recommended daily dose is 10 mg of bisoprolol.
Depending on how well you tolerate the medicine, your doctor may also decide to prolong the time between dose increases. If your condition worsens or you no longer tolerate the medicine, it may be necessary to reduce the dose again or stop treatment. In some patients, a maintenance dose lower than 10 mg of bisoprolol may be sufficient.
Your doctor will tell you what to do.
Normally, if you need to stop treatment completely, your doctor will advise you to gradually reduce the dose, as otherwise, your condition may worsen.
If you take more Bisoprolol Tarbis Farma than you should
If you have taken more tablets of bisoprolol than you should, inform your doctor immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken. Your doctor will decide what measures are necessary. The symptoms of an overdose may include a reduction in heart rate, severe difficulty breathing, dizziness, or tremors (due to low blood sugar).
If you forget to take Bisoprolol Tarbis Farma
Do not take a double dose to make up for forgotten doses. Take your usual dose the next morning.
If you stop taking Bisoprolol Tarbis Farma
Never stop taking bisoprolol except on the advice of your doctor. Otherwise, your condition could worsen significantly.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
To prevent serious side effects, talk to a doctor immediately if a side effect is severe, occurs suddenly, or worsens rapidly.
The most serious side effects are related to heart function:
If you feel dizzy or weak, or have difficulty breathing, contact your doctor as soon as possible.
Other side effects are mentioned below according to their frequency of possible occurrence:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, after EXP. The expiry date is the last day of the month shown.
Store below 30°C.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Bisoprolol Tarbis Farma
The active substance is bisoprolol fumarate.
Each tablet contains 2.5 mg of bisoprolol fumarate.
The other ingredients are:
Core of the tablet: Microcrystalline cellulose, calcium hydrogen phosphate, crospovidone, colloidal anhydrous silica, magnesium stearate.
Film coating: Poly(vinyl alcohol) - partially hydrolyzed (E1203), titanium dioxide (E171), macrogol (E1521), talc (E553b), yellow iron oxide (E 172)
Appearance of the product and contents of the pack
Film-coated tablets, biconvex, round in shape, yellow in colour, approximately 8.1 mm in diameter and 3.8 ± 0.3 mm in thickness, scored on one side with "2" and "4" on either side of the score line and "H" and "B" on either side of the score line on the other side.
The tablet can be divided into two equal doses.
Blisters containing 28, 30, 50, 60, 90, 100, and 250 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder
Tarbis Farma S.L.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Manufacturer
Amarox Pharma B.V.
Rouboslaan 32
Voorschoten, 2252TR
Netherlands
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany: Bisoprolol Amarox 2.5 mg film-coated tablets
Netherlands: Bisoprolol Amarox 2.5 mg, film-coated tablets
Spain: Bisoprolol Tarbis Farma 2.5 mg film-coated tablets EFG
Date of the last revision of this leaflet:February 2024
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/